FAIRFAX, Va., Jan. 10, 2016 (GLOBE NEWSWIRE) -- Dr. Howard Budner & Associates offers Ortho-K, an affordable, non-surgical alternative to LASIK surgery. Ortho-K, which stands for Orthokeratology, uses specially designed gas permeable contact lenses to correct myopia. Patients wear the lenses while sleeping at night. The lenses gently reshape the cornea for clearer vision the following day. Vision improvement lasts for one to two days; for best results, lenses should be worn nightly. Ortho-K lenses are primarily used to correct refractive errors for nearsightedness and astigmatism. Ortho-K is also an effective treatment option for slowing the progression of childhood myopia.
Fairfax, VA and Rockville, MD patients searching for an affordable alternative to LASIK may benefit from Ortho-K, a non-surgical, reversible treatment offered through Dr. Howard Budner & Associates. “Ortho-K is most frequently used to temporarily correct myopia, although this non-surgical treatment can also correct lesser degrees of astigmatism," said optometrist Dr. Howard Budner. “The type and amount of correction depends on the patient’s vision needs and is handled on a case-by-case basis.”
Ortho-K is a non-surgical alternative to LASIK that uses specially fitted lenses to reshape a patient’s cornea at night. Patients wear the lenses while sleeping and remove them during the day to enjoy clear vision. The lenses reshape the eye’s surface, correcting refractive errors. These changes last one to two days, says Dr. Budner, who recommends patients wear the lenses each night for maximum vision correction benefit. “Many of our patients who use Ortho-K do so because they do not feel comfortable receiving LASIK surgery but also do not want to wear glasses or contact lenses during the day,” said Dr. Budner. “Ortho-K is also a great vision correction option for individuals who play sports or have jobs that make glasses or contacts uncomfortable or difficult to wear and for children.”
Most patients achieve 20/20 vision after Ortho-K, although the legal minimum for driving (20/40) is also an acceptable outcome. An FDA study of Paragon corneal refractive therapy (CRT) lenses, a proprietary lens correction method similar to Ortho-K, found that 93 percent of patients achieved 20/32 vision or better, and 67 percent achieved 20/20 or better over a nine month period.
In addition to providing temporary vision correction, Ortho-K may also help to slow the progression of myopia in children. A 2013 study published in Eye & Contact Lens found that children wearing Ortho-K contacts showed significantly more stable myopia when compared with those who did not and 64% of cases stabilized.
Dr. Howard Budner & Associates serve patients in Rockville, Fairfax, Potomac, Mclean, Vienna, Reston, Olney and Bethesda. The eye care centers offer more than 1,000 frames in stock and full range of optometry services, including eye disease diagnosis and treatment. For more information on Ortho-K or eye care, call 703-691-8008 or visit www.drbudner.com.
Dr. Howard Budner & Associates, 703-691-8008 and 301-871-0180


noyb Files GDPR Complaints Against TikTok, Grindr, and AppsFlyer Over Alleged Illegal Data Tracking.
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Amazon in Talks to Invest $10 Billion in OpenAI as AI Firm Eyes $1 Trillion IPO Valuation
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Oracle Stock Slides After Blue Owl Exit Report, Company Says Michigan Data Center Talks Remain on Track
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 



